Lempp FA, et al.Nature. 2021 Aug 31. doi: 10.1038/s41586-021-03925-1. Online ahead of print.Nature. 2021.PMID: 34464958.
. No abstract available.
.
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.
Cudkowicz M, Genge A, Maragakis N, Petri S, van den Berg L, Aho VV, Sarapohja T, Kuoppamäki M, Garratt C, Al-Chalabi A; REFALS investigators.. Cai G, et al.Gastroenterology. 2021 Sep 3:S0016-5085(21)03473-9. doi: 10.1053/j.gastro.2021.08.054. Online ahead of print.Gastroenterology. 2021.PMID: 34487783.